4 Results for "

Erythropoiesis-stimulating

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "Erythropoiesis-stimulating" in MCE Product Catalog:

9
9 Cited Publications
Cat. No.: HY-101277
CAS No.: 1000025-07-9
Purity:  99.83%
Synonyms: PG-1016548; AKB-6548
Research Areas:  

Cardiovascular Disease

Vadadustat (PG-1016548) is a titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor . Vadadustat is an erythropoiesis-stimulating agent and has the potential for anemia treatment in chronic kidney disease in vivo .
loading...
    loading...
Cat. No.: HY-101277S1
Synonyms: PG-1016548-13C6; AKB-6548-13C6
Vadadustat- 13C6 (PG-1016548- 13C6) is 13C labeled Vadadustat. Vadadustat (PG-1016548) is a titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor . Vadadustat is an erythropoiesis-stimulating agent and has the potential for anemia treatment in chronic kidney disease in vivo .
loading...
    loading...
Cat. No.: HY-101277R
CAS No.: 1000025-07-9
Synonyms: PG-1016548 (Standard); AKB-6548 (Standard)
Vadadustat (Standard) is the analytical standard of Vadadustat (HY-101277). This product is intended for research and analytical applications. Vadadustat (PG-1016548) is a titratable, oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor . Vadadustat is an erythropoiesis-stimulating agent and has the potential for anemia treatment in chronic kidney disease in vivo .
loading...
    loading...
Cat. No.: HY-108864
CAS No.: 113427-24-0
Synonyms: Epogen

Research Areas:  

Cardiovascular Disease Cancer

Epoetin alfa (Epogen) is a recombinant human erythropoietin whose amino acid sequence and biological activity are identical to those of endogenous erythropoietin (EPO). Epoetin alfa is a direct agonist of the EPO receptor (EPOR) on the surface of erythroid progenitor cells, and promotes the production and maturation of red blood cells. Epoetin alfa can be used for research on myelodysplastic syndrome-related anemia and hematological malignancies .
loading...
    loading...